303 related articles for article (PubMed ID: 19812251)
1. A mutation associated with CMT2A neuropathy causes defects in Fzo1 GTP hydrolysis, ubiquitylation, and protein turnover.
Amiott EA; Cohen MM; Saint-Georges Y; Weissman AM; Shaw JM
Mol Biol Cell; 2009 Dec; 20(23):5026-35. PubMed ID: 19812251
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial Dysfunction and Pharmacodynamics of Mitofusin Activation in Murine Charcot-Marie-Tooth Disease Type 2A.
Franco A; Dang X; Zhang L; Molinoff PB; Dorn GW
J Pharmacol Exp Ther; 2022 Nov; 383(2):137-148. PubMed ID: 36507849
[TBL] [Abstract][Full Text] [Related]
3. Ugo1 and Mdm30 act sequentially during Fzo1-mediated mitochondrial outer membrane fusion.
Anton F; Fres JM; Schauss A; Pinson B; Praefcke GJ; Langer T; Escobar-Henriques M
J Cell Sci; 2011 Apr; 124(Pt 7):1126-35. PubMed ID: 21385840
[TBL] [Abstract][Full Text] [Related]
4. Sequential requirements for the GTPase domain of the mitofusin Fzo1 and the ubiquitin ligase SCFMdm30 in mitochondrial outer membrane fusion.
Cohen MM; Amiott EA; Day AR; Leboucher GP; Pryce EN; Glickman MH; McCaffery JM; Shaw JM; Weissman AM
J Cell Sci; 2011 May; 124(Pt 9):1403-10. PubMed ID: 21502136
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial fusion and function in Charcot-Marie-Tooth type 2A patient fibroblasts with mitofusin 2 mutations.
Amiott EA; Lott P; Soto J; Kang PB; McCaffery JM; DiMauro S; Abel ED; Flanigan KM; Lawson VH; Shaw JM
Exp Neurol; 2008 May; 211(1):115-27. PubMed ID: 18316077
[TBL] [Abstract][Full Text] [Related]
6. MITOL-mediated DRP1 ubiquitylation and degradation promotes mitochondrial hyperfusion in a CMT2A-linked MFN2 mutant.
Das R; Kamal IM; Das S; Chakrabarti S; Chakrabarti O
J Cell Sci; 2022 Jan; 135(2):. PubMed ID: 34870686
[TBL] [Abstract][Full Text] [Related]
7. Burst mitofusin activation reverses neuromuscular dysfunction in murine CMT2A.
Franco A; Dang X; Walton EK; Ho JN; Zablocka B; Ly C; Miller TM; Baloh RH; Shy ME; Yoo AS; Dorn GW
Elife; 2020 Oct; 9():. PubMed ID: 33074106
[TBL] [Abstract][Full Text] [Related]
8. Structural insights of human mitofusin-2 into mitochondrial fusion and CMT2A onset.
Li YJ; Cao YL; Feng JX; Qi Y; Meng S; Yang JF; Zhong YT; Kang S; Chen X; Lan L; Luo L; Yu B; Chen S; Chan DC; Hu J; Gao S
Nat Commun; 2019 Oct; 10(1):4914. PubMed ID: 31664033
[TBL] [Abstract][Full Text] [Related]
9. Dual role of a GTPase conformational switch for membrane fusion by mitofusin ubiquitylation.
Schuster R; Anton V; Simões T; Altin S; den Brave F; Hermanns T; Hospenthal M; Komander D; Dittmar G; Dohmen RJ; Escobar-Henriques M
Life Sci Alliance; 2020 Jan; 3(1):. PubMed ID: 31857350
[TBL] [Abstract][Full Text] [Related]
10. Role of mitofusin 2 mutations in the physiopathology of Charcot-Marie-Tooth disease type 2A.
Cartoni R; Martinou JC
Exp Neurol; 2009 Aug; 218(2):268-73. PubMed ID: 19427854
[TBL] [Abstract][Full Text] [Related]
11. Plasticity in salt bridge allows fusion-competent ubiquitylation of mitofusins and Cdc48 recognition.
Anton V; Buntenbroich I; Schuster R; Babatz F; Simões T; Altin S; Calabrese G; Riemer J; Schauss A; Escobar-Henriques M
Life Sci Alliance; 2019 Dec; 2(6):. PubMed ID: 31740565
[TBL] [Abstract][Full Text] [Related]
12. A human mitofusin 2 mutation can cause mitophagic cardiomyopathy.
Franco A; Li J; Kelly DP; Hershberger RE; Marian AJ; Lewis RM; Song M; Dang X; Schmidt AD; Mathyer ME; Edwards JR; Strong CG; Dorn GW
Elife; 2023 Nov; 12():. PubMed ID: 37910431
[TBL] [Abstract][Full Text] [Related]
13. MFN2 mutations cause severe phenotypes in most patients with CMT2A.
Feely SM; Laura M; Siskind CE; Sottile S; Davis M; Gibbons VS; Reilly MM; Shy ME
Neurology; 2011 May; 76(20):1690-6. PubMed ID: 21508331
[TBL] [Abstract][Full Text] [Related]
14. A cohort study of Han Chinese MFN2-related Charcot-Marie-Tooth 2A.
Lv H; Wang L; Zhang W; Wang Z; Zuo Y; Liu J; Yuan Y
J Neurol Sci; 2015 Nov; 358(1-2):153-7. PubMed ID: 26382835
[TBL] [Abstract][Full Text] [Related]
15. Torin1 restores proliferation rate in Charcot-Marie-Tooth disease type 2A cells harbouring MFN2 (mitofusin 2) mutation.
Zanfardino P; Amati A; Petracca EA; Santorelli FM; Petruzzella V
Acta Myol; 2022; 41(4):201-206. PubMed ID: 36793649
[TBL] [Abstract][Full Text] [Related]
16. Mitofusin 1 overexpression rescues the abnormal mitochondrial dynamics caused by the Mitofusin 2 K357T mutation in vitro.
Stavropoulos F; Georgiou E; Schiza N; Bell S; Baloh RH; Kleopa KA; Sargiannidou I
J Peripher Nerv Syst; 2023 Sep; 28(3):329-340. PubMed ID: 37220142
[TBL] [Abstract][Full Text] [Related]
17. Charcot-Marie-Tooth type 2A in vivo models: Current updates.
Abati E; Rizzuti M; Anastasia A; Comi GP; Corti S; Rizzo F
J Cell Mol Med; 2024 May; 28(9):e18293. PubMed ID: 38722298
[TBL] [Abstract][Full Text] [Related]
18. The Effect of a Novel c.820C>T (Arg274Trp) Mutation in the Mitofusin 2 Gene on Fibroblast Metabolism and Clinical Manifestation in a Patient.
Beręsewicz M; Boratyńska-Jasińska A; Charzewski Ł; Kawalec M; Kabzińska D; Kochański A; Krzyśko KA; Zabłocka B
PLoS One; 2017; 12(1):e0169999. PubMed ID: 28076385
[TBL] [Abstract][Full Text] [Related]
19. Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutations.
Detmer SA; Chan DC
J Cell Biol; 2007 Feb; 176(4):405-14. PubMed ID: 17296794
[TBL] [Abstract][Full Text] [Related]
20. Increased mitochondrial fusion in a autosomal recessive CMT2A family with mitochondrial GTPase mitofusin 2 mutations.
Codron P; Chevrollier A; Kane MS; Echaniz-Laguna A; Latour P; Reynier P; Bonneau D; Verny C; Procaccio V; Lenaers G; Cassereau J
J Peripher Nerv Syst; 2016 Dec; 21(4):365-369. PubMed ID: 27706887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
